Efficacy and Safety of Stem Cell Therapy for T1DM: An Updated Systematic Review and Meta-Analysis
Background. The long-term insulin therapy for type 1 diabetes mellitus (T1DM) fails to achieve optimal glycemic control and avoid adverse events simultaneously. Stem cells have unique immunomodulatory capacities and have been considered as a promising interventional strategy for T1DM. Stem cell ther...
Main Authors: | Shi-Yi Sun, Yun Gao, Guan-Jian Liu, Yong-Kun Li, Wei Gao, Xing-Wu Ran |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2020/5740923 |
Similar Items
-
Safety and efficacy of hematopoietic and mesanchymal stem cell therapy for treatment of T1DM: a systematic review and meta-analysis protocol
by: Sedigheh Madani, et al.
Published: (2018-01-01) -
Systematic review with meta-analysis: the efficacy and safety of stem cell therapy for Crohn’s disease
by: Yun Qiu, et al.
Published: (2017-06-01) -
Efficacy and safety of stem cell therapy in patients with dilated cardiomyopathy: a systematic appraisal and meta-analysis
by: Shu-Ling Rong, et al.
Published: (2019-07-01) -
Efficacy and Safety of Stem Cell Combination Therapy for Osteonecrosis of the Femoral Head: A Systematic Review and Meta-Analysis
by: Junqiao Li, et al.
Published: (2021-01-01) -
The Efficacy of Mesenchymal Stem Cell Therapies in Rodent Models of Multiple Sclerosis: An Updated Systematic Review and Meta-Analysis
by: Jialin He, et al.
Published: (2021-08-01)